[MAHSING] QoQ TTM Result on 31-Mar-2019 [#1]

Stock
[MAHSING] MAH SING GROUP BHD
Announcement Date
30-May-2019
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2019
Quarter
31-Mar-2019 [#1]
Profit Trend
QoQ- -3.38%
YoY- -21.83%
Quarter Report
Latest QR
Upcoming QR
MAHSING's Result
MAHSING's Financial Summary
View:
Show?
TTM Result
31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 CAGR
Revenue 1,789,693 1,861,700 1,950,482 2,058,511 2,192,933 2,439,128 2,639,136 -22.75%
PBT 270,219 296,007 307,365 335,418 347,610 376,640 413,972 -24.69%
Tax -67,626 -74,301 -73,368 -74,788 -76,991 -83,961 -93,344 -19.28%
NP 202,593 221,706 233,997 260,630 270,619 292,679 320,628 -26.30%
-
NP to SH 200,334 221,364 235,582 262,395 271,582 294,340 322,416 -27.12%
-
Tax Rate 25.03% 25.10% 23.87% 22.30% 22.15% 22.29% 22.55% -
Total Cost 1,587,100 1,639,994 1,716,485 1,797,881 1,922,314 2,146,449 2,318,508 -22.27%
-
Net Worth 3,495,869 3,471,592 3,447,315 3,520,146 3,495,869 3,447,315 3,398,761 1.89%
Dividend
31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 CAGR
Div 81,327 109,245 109,245 109,245 109,245 157,474 157,474 -35.55%
Div Payout % 40.60% 49.35% 46.37% 41.63% 40.23% 53.50% 48.84% -
Equity
31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 CAGR
Net Worth 3,495,869 3,471,592 3,447,315 3,520,146 3,495,869 3,447,315 3,398,761 1.89%
NOSH 2,427,687 2,427,687 2,427,687 2,427,687 2,427,687 2,427,687 2,427,687 0.00%
Ratio Analysis
31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 CAGR
NP Margin 11.32% 11.91% 12.00% 12.66% 12.34% 12.00% 12.15% -
ROE 5.73% 6.38% 6.83% 7.45% 7.77% 8.54% 9.49% -
Per Share
31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 CAGR
RPS 73.72 76.69 80.34 84.79 90.33 100.47 108.71 -22.75%
EPS 8.25 9.12 9.70 10.81 11.19 12.12 13.28 -27.13%
DPS 3.35 4.50 4.50 4.50 4.50 6.50 6.49 -35.57%
NAPS 1.44 1.43 1.42 1.45 1.44 1.42 1.40 1.89%
Adjusted Per Share Value based on latest NOSH - 2,427,687
31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 CAGR
RPS 69.91 72.72 76.19 80.41 85.66 95.27 103.09 -22.75%
EPS 7.83 8.65 9.20 10.25 10.61 11.50 12.59 -27.07%
DPS 3.18 4.27 4.27 4.27 4.27 6.15 6.15 -35.50%
NAPS 1.3655 1.356 1.3465 1.375 1.3655 1.3465 1.3276 1.88%
Price Multiplier on Financial Quarter End Date
31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 CAGR
Date 31/12/19 30/09/19 28/06/19 29/03/19 31/12/18 28/09/18 29/06/18 -
Price 0.705 0.75 0.92 0.93 0.915 1.02 1.07 -
P/RPS 0.96 0.98 1.15 1.10 1.01 1.02 0.98 -1.36%
P/EPS 8.54 8.23 9.48 8.60 8.18 8.41 8.06 3.92%
EY 11.71 12.16 10.55 11.62 12.23 11.89 12.41 -3.78%
DY 4.75 6.00 4.89 4.84 4.92 6.37 6.06 -14.95%
P/NAPS 0.49 0.52 0.65 0.64 0.64 0.72 0.76 -25.30%
Price Multiplier on Announcement Date
31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 CAGR
Date 28/02/20 27/11/19 30/08/19 30/05/19 27/02/19 16/11/18 30/08/18 -
Price 0.675 0.69 0.865 0.905 1.00 1.03 1.18 -
P/RPS 0.92 0.90 1.08 1.07 1.11 1.03 1.09 -10.66%
P/EPS 8.18 7.57 8.91 8.37 8.94 8.50 8.89 -5.38%
EY 12.23 13.21 11.22 11.94 11.19 11.77 11.25 5.71%
DY 4.96 6.52 5.20 4.97 4.50 6.31 5.50 -6.63%
P/NAPS 0.47 0.48 0.61 0.62 0.69 0.73 0.84 -32.02%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment